
Gvr Biologics Private Limited
Founded in 2023 and headquartered in Andhra Pradesh, India.
Founded in 2023 and headquartered in Andhra Pradesh, India.
Gvr Biologics Private Limited (GBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 March 2023 (Two years 1 days old ). Its registered office is in Krishna, Andhra Pradesh, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkateswara Gogineni and Supriya Kunchala serve as directors at the Company.
Krishna, Andhra Pradesh, India
+91-XXXXXXXXXX
U86100AP2023PTC110640
110640
Private Limited Indian Non-Government Company
28 Mar 2023
-
-
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkateswara Gogineni ![]() | Director | 25-Sep-2024 | Current |
Supriya Kunchala | Director | 25-Sep-2024 | Current |
Enhance accessibility to Gvr Biologics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Gvr Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Venkateswara Gogineni is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gvr Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gvr Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gvr Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Venkateswara Rao Gogineni was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 6 months 3 days .
Supriya Kunchala was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 6 months 3 days .
Gvr Biologics Private Limited was registered on 28 Mar 2023 with Roc Vijayawada & aged 2 years 1 day as per MCA records.
Gvr Biologics Private Limited was incorporated on 28 Mar 2023.
The authorized share capital of Gvr Biologics Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Gvr Biologics Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Gvr Biologics Private Limited is D No 40 6 4 12 Vijayawada Municipal Corporation Revenue Ward 18, (Urban) India, Vijayawada (Urban), Andhra Pradesh, 520010.
The corporate identification number (CIN) of Gvr Biologics Private Limited is U86100AP2023PTC110640 and the company number is 110640 as per Ministry of Corporate Affairs (MCA).
ST